Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans (Q38156497)

29 August 2017

title

Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans (English)

1 reference

29 August 2017

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171859 AND SRC:MED&resulttype=core&format=json

4 June 2020

Neil Wedlock

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171859 AND SRC:MED&resulttype=core&format=json

4 June 2020

Axel Heiser

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171859 AND SRC:MED&resulttype=core&format=json

4 June 2020

author name string

N A Parlane

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171859 AND SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

1 reference

1 November 2013

1 reference

Transboundary and Emerging Diseases

29 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171859 AND SRC:MED&resulttype=core&format=json

4 June 2020

volume

60 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171859 AND SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

136-146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24171859 AND SRC:MED&resulttype=core&format=json

The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4 and CD8 T cells in adults

4 June 2020

cites work

1 reference

Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums

21 January 2018

1 reference

Field evaluation of the efficacy of Mycobacterium bovis bacillus Calmette-Guerin against bovine tuberculosis in neonatal calves in Ethiopia

21 January 2018

1 reference

Trial design to estimate the effect of vaccination on tuberculosis incidence in badgers.

21 January 2018

1 reference

A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis

21 January 2018

1 reference

Revaccination of neonatal calves with Mycobacterium bovis BCG reduces the level of protection against bovine tuberculosis induced by a single vaccination.

21 January 2018

1 reference

Delaying bacillus Calmette-Guérin vaccination from birth to 4 1/2 months of age reduces postvaccination Th1 and IL-17 responses but leads to comparable mycobacterial responses at 9 months of age.

21 January 2018

1 reference

Combined DNA vaccines formulated either in DDA or in saline protect cattle from Mycobacterium bovis infection

21 January 2018

1 reference

Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers.

21 January 2018

1 reference

Tuberculosis in European badgers (Meles meles) and the control of infection with bacille Calmette-Guérin vaccination.

21 January 2018

1 reference

Lipid-formulated bcg as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy, and palatability to brushtail possums (Trichosurus vulpecula) in New Zealand

21 January 2018

1 reference

Recombinant BCG ΔureC hly induces superior protection over parental BCG by stimulating a balanced combination of type 1 and type 17 cytokine responses

21 January 2018

1 reference

Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis

21 January 2018

1 reference

Efficacy of percutaneous versus intradermal BCG in the prevention of tuberculosis in South African infants: randomised trial

21 January 2018

1 reference

A new recombinant bacille Calmette-Guérin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers

21 January 2018

1 reference

Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis

21 January 2018

1 reference

Exposure to Mycobacterium avium induces low-level protection from Mycobacterium bovis infection but compromises diagnosis of disease in cattle.

21 January 2018

1 reference

Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish

21 January 2018

1 reference

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells

21 January 2018

1 reference

BCG vaccination failed to protect yearling African buffaloes (Syncerus caffer) against experimental intratonsilar challenge with Mycobacterium bovis

21 January 2018

1 reference

Taking a New Shot At a TB Vaccine

21 January 2018

1 reference

Protection of Eurasian badgers (Meles meles) from tuberculosis after intra-muscular vaccination with different doses of BCG

21 January 2018

1 reference

The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection

21 January 2018

1 reference

Regionalization: a strategy that will assist with bovine tuberculosis control and facilitate trade

21 January 2018

1 reference

Field evaluation of the protective efficacy of Mycobacterium bovis BCG vaccine against bovine tuberculosis

21 January 2018

1 reference

The impact of a change in bacille Calmette-Guérin vaccine policy on tuberculosis incidence in children in Cape Town, South Africa

21 January 2018

1 reference

The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs

21 January 2018

1 reference

Managing the wildlife reservoir of Mycobacterium bovis: the Michigan, USA, experience

21 January 2018

1 reference

Vaccines against tuberculosis: where are we and where do we need to go?

21 January 2018

1 reference

Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis

21 January 2018

1 reference

Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis

21 January 2018

1 reference

The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur

21 January 2018

1 reference

Beneficial non-targeted effects of BCG--ethical implications for the coming introduction of new TB vaccines

21 January 2018

1 reference

Tuberculosis vaccines in clinical trials

21 January 2018

1 reference

Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4 T cells

21 January 2018

1 reference

A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis

21 January 2018

1 reference

The order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.

21 January 2018

1 reference

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis

21 January 2018

1 reference

Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.

21 January 2018

1 reference

Prophylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosis

21 January 2018

1 reference

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis

21 January 2018

1 reference

Mycobacterium bovis antigens for the differential diagnosis of vaccinated and infected cattle

21 January 2018

1 reference

Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.

21 January 2018

1 reference

Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves

21 January 2018

1 reference

Bovine tuberculosis vaccine research: historical perspectives and recent advances.

21 January 2018

1 reference

Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone.

21 January 2018

1 reference

Vaccination of cattle with Danish and Pasteur strains of Mycobacterium bovis BCG induce different levels of IFNgamma post-vaccination, but induce similar levels of protection against bovine tuberculosis

21 January 2018

1 reference

Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone

21 January 2018

1 reference

Development of a skin test for bovine tuberculosis for differentiating infected from vaccinated animals

21 January 2018

1 reference

Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen

21 January 2018

1 reference